Residency · Residency · Obstetrics Gynecology
Chronic Pelvic Pain: Multidisciplinary Approach
Definition
Chronic pelvic pain is non-cyclical pain in the pelvis lasting 6 months or longer that is severe enough to cause functional disability or require treatment. It affects 15 to 20% of women aged 18 to 50. The condition is often multifactorial, with multiple contributors rather than a single cause. It has a significant impact on quality of life, relationships, work productivity, and mental health.
Differential Diagnosis
Gynecologic
Endometriosis is the most common gynecologic cause. Additional gynecologic causes include adenomyosis, chronic pelvic inflammatory disease or endometritis, ovarian remnant syndrome (after incomplete oophorectomy), residual ovary syndrome (adhesions around a remaining ovary), pelvic adhesions from prior surgery, vulvodynia or vestibulodynia, and pelvic congestion syndrome from dilated pelvic veins.
Urologic
Interstitial cystitis/bladder pain syndrome is the most important urologic cause to consider. Recurrent UTI, urethral diverticulum, and urethral syndrome are additional diagnoses.
Gastrointestinal
Irritable bowel syndrome is the most common non-gynecologic cause of chronic pelvic pain. Inflammatory bowel disease (Crohn disease and ulcerative colitis), chronic constipation, and diverticular disease are other gastrointestinal considerations.
Musculoskeletal
Pelvic floor myalgia and hypertonic pelvic floor are extremely common contributors and frequently overlooked. Myofascial trigger points in the abdominal wall and pelvic floor, abdominal wall nerve entrapment (ilioinguinal and iliohypogastric nerves), coccygodynia, sacroiliac joint dysfunction, and hip pathology are all in the musculoskeletal differential.
Neurologic
Pudendal neuralgia, central sensitization or chronic pain syndrome, and post-surgical neuropathy represent neurologic causes.
Psychological
Depression, anxiety, and PTSD are important contributors. A history of physical or sexual abuse is present in 40 to 50% of chronic pelvic pain patients. Catastrophizing and fear avoidance behaviors also play a role.
<image>Venn diagram showing the overlap of contributing factors in chronic pelvic pain: gynecologic causes (endometriosis, adenomyosis), urologic (IC/BPS), gastrointestinal (IBS), musculoskeletal (pelvic floor myalgia), neurologic (central sensitization), and psychosocial (depression, trauma history), illustrating how most patients have multiple concurrent contributors</image>
Evaluation
History
The history should characterize pain location, quality, severity (using VAS or NRS), timing (cyclical versus non-cyclical), and radiation. Aggravating and alleviating factors are documented. The relationship to the menstrual cycle, intercourse, and bladder and bowel function is explored. Associated symptoms including dysmenorrhea, dyspareunia, urinary urgency and frequency, and bowel symptoms are assessed. Surgical history (which determines adhesion risk), obstetric history, sexual history, sexual function, and relationship quality are all relevant. Psychological screening should include the PHQ-9 for depression, GAD-7 for anxiety, ACE score for adverse childhood experiences, and inquiry about trauma history. Previous treatments and their effectiveness, as well as the impact on daily function and quality of life, should be documented.
Physical Exam
The abdominal exam includes the Carnett sign: the tender area is palpated and then the patient tenses the abdominal wall by performing a partial sit-up. If pain worsens, an abdominal wall source (myofascial pain or nerve entrapment) is likely; if pain decreases, a visceral source is suggested. Trigger point assessment of the abdominal wall is performed. The external genital exam inspects for vulvar lesions and erythema associated with vulvodynia. The Q-tip test evaluates for vestibulodynia by identifying point tenderness at the vestibular glands.
The single-digit vaginal exam is frequently the most revealing part of the evaluation. The pelvic floor muscles are systematically palpated, including the levator ani (pubococcygeus, iliococcygeus, puborectalis) and obturator internus. Trigger points, hypertonicity, and tenderness are identified. The bimanual exam assesses uterine size, tenderness, adnexal masses, and uterosacral nodularity. A rectovaginal exam evaluates for endometriosis nodularity in the rectovaginal septum.
Diagnostics
Laboratory testing includes CBC, urinalysis and culture, STI screening, ESR and CRP if an inflammatory etiology is suspected, and pregnancy test. Transvaginal ultrasound evaluates the uterus for fibroids and adenomyosis, the ovaries for endometriomas and masses, and free fluid. MRI is indicated when deep infiltrating endometriosis is suspected or when pelvic floor and nerve assessment is needed. Specialized testing may include potassium sensitivity testing or cystoscopy with hydrodistension for interstitial cystitis/bladder pain syndrome, colonoscopy if GI symptoms warrant evaluation, and nerve blocks (pudendal, ilioinguinal) for diagnostic and therapeutic purposes. Laparoscopy is not first-line and should be considered when empiric medical management fails and endometriosis or adhesions are suspected.
Management Principles
Biopsychosocial Framework
Treatment should address biological, psychological, and social contributors simultaneously. A multidisciplinary team including a gynecologist, pelvic floor physical therapist, pain psychologist, gastroenterologist, and urologist optimizes outcomes. Realistic expectations must be set: the goal is improved function and quality of life, not necessarily complete pain elimination. Repeated surgeries without clear surgical indication should be avoided.
Pelvic Floor Physical Therapy
Pelvic floor physical therapy is the first-line treatment for the musculoskeletal component. It addresses pelvic floor hypertonicity, trigger points, and myofascial restrictions through techniques including manual therapy (internal and external), biofeedback, progressive relaxation, stretching, and core stabilization. Typically 6 to 12 sessions are needed for benefit. It is effective for chronic pelvic pain, vulvodynia, interstitial cystitis/bladder pain syndrome, and dyspareunia. The evidence base is strong, but the modality remains underutilized.
Psychological Support
Cognitive behavioral therapy is the most evidence-based psychological treatment for chronic pain. It addresses catastrophizing, fear avoidance, and coping strategies. Trauma-focused therapy using EMDR or prolonged exposure is indicated for PTSD-related pain. Mindfulness-based stress reduction and acceptance and commitment therapy are additional options.
Pharmacologic Management
For Neuropathic/Central Pain
Gabapentin at 300 to 3,600 mg daily in divided doses (starting low and titrating slowly), pregabalin at 75 to 300 mg twice daily, amitriptyline at 10 to 75 mg nightly (a tricyclic antidepressant that modulates pain centrally), duloxetine at 30 to 60 mg daily (an SNRI with dual pain and mood benefit), and nortriptyline (an alternative TCA with fewer anticholinergic effects) are all options.
For Endometriosis-Related Pain
Hormonal suppression with continuous oral contraceptives, progestins, levonorgestrel IUD, or GnRH agonists/antagonists is employed. NSAIDs address cyclical pain.
For IC/BPS
Amitriptyline at 10 to 75 mg nightly, pentosan polysulfate (Elmiron) at 100 mg three times daily (though use is declining due to maculopathy risk), intravesical instillations of heparin, lidocaine, or DMSO, and dietary modifications to avoid bladder irritants are used.
For IBS
Dietary modification including the low-FODMAP diet, antispasmodics (hyoscyamine, dicyclomine), and neuromodulators (TCAs, SSRIs) are the mainstays of treatment.
Analgesics
NSAIDs address inflammatory pain. Acetaminophen serves as an adjunct. Opioids should be avoided for chronic pelvic pain whenever possible because of the risk of dependence, hyperalgesia, and the absence of evidence for long-term benefit. Muscle relaxants including diazepam vaginal suppositories (2 to 10 mg) for pelvic floor spasm and cyclobenzaprine may be helpful.
Interventional Procedures
Trigger point injections using local anesthetic with or without corticosteroid target abdominal wall or pelvic floor trigger points. Pudendal nerve blocks serve both diagnostic and therapeutic purposes. Ilioinguinal and iliohypogastric nerve blocks are used for abdominal wall nerve entrapment. Botulinum toxin injection for pelvic floor hypertonicity is off-label but has emerging evidence. Sacral neuromodulation is used for refractory interstitial cystitis/bladder pain syndrome. Presacral neurectomy for midline pain is rarely performed.
Surgical Management
Laparoscopy is appropriate for suspected endometriosis, adhesiolysis, or ovarian pathology. Evidence for adhesiolysis alone in chronic pelvic pain is mixed, as adhesions may reform and placebo-controlled trials show limited benefit. Hysterectomy is a last resort for uterine-source pain such as adenomyosis or refractory dysmenorrhea and is not a cure for chronic pelvic pain of non-uterine origin. Outcomes are best when specific pathology is identified and targeted.
<image>Multidisciplinary treatment approach for chronic pelvic pain showing the central role of the patient surrounded by contributing team members: gynecologist managing endometriosis and uterine pathology, pelvic floor physical therapist addressing musculoskeletal factors, pain psychologist for CBT and trauma processing, and specialists (urogynecologist, gastroenterologist, pain medicine) addressing organ-specific conditions</image>
Clinical Pearls
Chronic pelvic pain is almost always multifactorial. A single-cause approach will fail. All contributing factors must be identified and treated.
Pelvic floor myalgia is present in the majority of chronic pelvic pain patients and is often overlooked. A single-digit pelvic floor exam is the most important part of the evaluation.
Pelvic floor physical therapy is first-line treatment for the musculoskeletal component and is critically underutilized.
The Carnett sign helps distinguish abdominal wall pain (worsens with tensing) from visceral pain (improves with tensing). This simple test prevents unnecessary surgery.
Chronic opioid use should be avoided for chronic pelvic pain. It does not improve outcomes and creates dependence and hyperalgesia.
A history of physical or sexual abuse is present in 40 to 50% of chronic pelvic pain patients. Screen sensitively and refer for trauma-focused therapy.
Repeated surgeries without clear indication worsen outcomes by creating adhesions and reinforcing pain behaviors. Non-surgical options should be exhausted first.
Hysterectomy should only be performed for chronic pelvic pain when a specific uterine cause is identified (such as adenomyosis) and conservative treatments have failed.
References
- ACOG Practice Bulletin No. 218: Chronic Pelvic Pain (2020)
- Fall M et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57:35-48
- Howard FM. Chronic pelvic pain. Obstet Gynecol. 2003;101:594-611
- Jarrell JF et al. SOGC Clinical Practice Guideline: Chronic Pelvic Pain. J Obstet Gynaecol Can. 2005;27:869-910
- Tu FF et al. Musculoskeletal causes of chronic pelvic pain. Obstet Gynecol. 2006;107:915-923
- Allaire C et al. An interdisciplinary approach to chronic pelvic pain. J Obstet Gynaecol Can. 2018;40:1044-1055
